As part of the Jobs, Growth, and Long-Term Prosperity Act, the Harper Government today introduced amendments to the Food and Drugs Act that will continue to protect Canadian food safety, while reducing red tape that currently delays safe foods from getting to market. read more...

The Honourable Leona Aglukkaq, Minister of Health, announced today that Economic Action Plan 2012 cuts red tape that currently delays access for Canadians to new over-the-counter (OTC) drugs. read more...

Following our March 21, 2012, Notice to Hospitals and Notice to Healthcare Professionals, Health Canada is advising Canadians that Sandoz Canada Inc. will be voluntarily recalling a portion of one lot of 2mg/mL (1mL) Morphine Sulfate Injection (Lot CC2824 exp. 2014-12) from the Canadian market. The recall applies to all products that has been distributed to healthcare providers. read more...

Health Canada is reminding Canadians of the importance of food safety for people with weakened immune systems. read more...

As part of the Government of Canada’s commitment to reducing the rate of tuberculosis (TB) among Canada’s First Nations people, the Honourable Leona Aglukkaq, Minister of Health, today released Health Canada’s Strategy Against Tuberculosis for First Nations On-Reserve read more...

Effective today, tobacco manufacturers and importers will now be restricted to distributing and selling cigarette and little cigar packages with the new health warning messages and other labelling changes. read more...

The Honourable Leona Aglukkaq, Minister of Health, today announced funding for a nation-wide multi-year Healthy Eating Awareness and Education Initiative. read more...

Bob Zimmer, Member of Parliament for Prince George – Peace River, on behalf of the Honourable Leona Aglukkaq, Minister of Health, announced today funding for a research project to improve access to quality nursing services in rural and remote Canada, including First Nations communities. read more...

Health Canada is informing Canadians of an ongoing safety review of the multiple sclerosis (MS) drug Gilenya (the brand name for fingolimod). The review was initiated following reports of serious adverse events, including 11 deaths reported internationally. No deaths have been reported in Canada. read more...

Health Canada is informing health professionals and the public that the prescription drugs finasteride and dutasteride may be associated with an increased risk of developing a serious form of prostate cancer known as high-grade prostate cancer. read more...

Health Canada is informing Canadians that Vita Health Products is conducting a voluntary recall of lot 00058398B of the ”combo pack” Rexall Extra Strength Sinus Relief Daytime and Nightime Caplets due to a labelling error that misidentifies the daytime and nighttime medications the lot number is printed on the blister pack just above the expiry date). read more...

Health Canada is informing Canadians that Apotex Incorporated is conducting a voluntary recall of one lot of Apo-Ramipril 5mg Capsules used to treat hypertension (high blood pressure). The recall of Lot JR2178 was made to retail outlets across Canada. read more...

An unauthorized health product, “Power-X” has been removed from a Canadian retail location after Health Canada’s testing identified undeclared thiodimethylsildenafil which is similar to the prescription medication sildenfil. read more...